Centene Corp (CNC)
Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell
$64.60
Buy
$66.02
$-0.87 (-1.31%)
Prices updated at 11 Jun 2026, 00:45 EDT
| Prices minimum 15 mins delay
Prices in USD
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of m ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 163,071m | 194,777m | |
| 16,829m | 13,867m | |
| 3,188m | -312m | |
| 1.96 | -0.16 | |
| 3,305m | -6,674m | |
| 6,200m | -4,775m | |
| Sales, General and administrative | 12,400m | 12,904m |
| Interest expenses | 702m | 678m |
| Provision for income taxes | 963m | -51m |
| Operating expenses | 13,641m | 14,179m |
| Income before taxes | 4,257m | -6,728m |
| Net income available to common shareholders | 3,305m | -6,674m |
| 6.33 | -13.53 | |
| Net interest income | -702m | -678m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 6.31 | -13.53 |
| Free cash flow per share | 0.46 | 6.769 |
| Book value/share | 55.0648 | 42.5983 |
| Debt equity ratio | 0.725521 | 0.900416 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 37,999m | 40,370m |
| Current liabilities | 34,261m | 36,696m |
| Total capital | 44,833m | 37,304m |
| Total debt | 19,429m | 18,162m |
| Total equity | 26,410m | 19,953m |
| Total non current liabilities | - | - |
| Loans | 18,423m | 17,351m |
| Total assets | 82,445m | 76,747m |
| Total liabilities | - | - |
| Cash and cash equivalents | 14,063m | 17,888m |
| Common stock | 496m | 492m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 17,452m | 14,156m |
| Cash dividends paid | - | - |
| -490m | 4,321m | |
| Investments (gains) losses | -1,052m | 472m |
| 14,156m | 17,957m | |
| Net income | - | - |
| 154m | 5,088m | |
| -644m | -767m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.